North American coral snake antivenin in 10 ML Injection
- RxCUI
- 1858981
- RxNorm name
- North American coral snake antivenin in 10 ML Injection
- Display name
- North American coral snake antivenin in 10 ML Injection
- Full name
- North American coral snake antivenin in 10 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 101099 | Antivenin (Micrurus fulvius) | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| North American Coral Snake Antivenin (Equine) | CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE) | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 6d0f94b4-82ca-37c7-edb0-4f0702cf6c8d | 2022-11-22 | Warnings, Adverse reactions | 1858981 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6d0f94b4-82ca-37c7-edb0-4f0702cf6c8d | North American coral snake antivenin in 10 ML Injection [PSN] · North American coral snake antivenin 250 UNT Injection [SCD] · North American coral snake antivenin 250 [arb'U] per 10 ML Injection [SY] | 3 | 7 | These highlights do not include all the information needed to use North American Coral Snake Antivenin (Equine) safely and effectively. See full prescribing information for North American Coral Snake Antivenin (Equine). North American Coral Snake Antivenin (Equine) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 1967 | 20221122 |